Baring Private Equity Asia announced that its affiliated private equity funds have agreed to acquire Lumenis, a provider of specialty energy-based medical devices across the fields of aesthetics, urology, ophthalmology, ENT and gynecology.
The transaction valued the Tel Aviv-based company at over $1 billion with the Asia Pacific region being its largest market.
“Lumenis has built a market-leading position by creating some of the most innovative technologies in the industry,” said Yan Jiao, managing director at Baring Private Equity Asia, commented: "It is a clear leader worldwide, especially in Asia  . . .
Continue Reading With a Free Trial
Unlock this article instantly, along with the rest of our premium content, newsletters and mandate charts.
Already a subscriber? Log in.